SCHEMBL31748749

SCHEMBL31748749

CCOP(=O)(CSc1c[nH]c2cc(F)c(Br)c(F)c12)OCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31748309 0.90 — —
SCHEMBL31748680 0.82 — —
SCHEMBL31748763 0.80 IDO1 (0.33) —
SCHEMBL31748500 0.72 GABRA1 (0.47) —
SCHEMBL31748699 0.72 GPR84 (0.34) —
SCHEMBL31748433 0.70 IDO1 (0.33) —
SCHEMBL22438703 0.70 GPR84 (0.45) —
SCHEMBL31748637 0.67 GPR84 (0.31) —
SCHEMBL25999701 0.67 GABRA1 (0.55) —
SCHEMBL16094453 0.66 ALOX5 (0.38) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250388571-A1 AMP-ACTIVATED PROTEIN KINASE MODULATOR COMPOUNDS AND USES THEREOF BIOLEXIS THERAPEUTICS INC (US) 2025-12-25 — — US disclosed
Send feedback